Khyber Teaching Hospital
Peshawar, Khyber Pakhtunkhwa, Pakistan
NCT Number: NCT07794540
This study compared two timings for primary single-stage surgery in female newborns with classic bladder exstrophy. Participants were randomly assigned to surgery within 72 hours of birth or at 6 to 12 weeks of age. Both groups received the same surgical repair and standardized perioperative care. The main outcome was successful closure of the bladder and abdominal wall 30 days after surgery. The study also evaluated wound dehiscence, surgical-site infection, urinary fistula, blood transfusion, reoperation, readmission, hospital stay, and adverse events.
Looking for future studies?
Notify Me0 day–2 day
Female
Interventional
Not applicable
Peshawar, Khyber Pakhtunkhwa, Pakistan
Eligible phenotypic female neonates who presented with classic bladder exstrophy within the first 48 hours of life and met the prespecified clinical and anaesthetic criteria were enrolled through consecutive sampling. After written consent and baseline assessment, participants were randomized in a 1:1 ratio using a computer-generated sequence with randomly varying block sizes and stratification by centre. Allocation was implemented through sequentially numbered sealed envelopes prepared independently of recruitment.
Participants assigned to early closure underwent primary single-stage repair within 72 hours of birth. Participants assigned to delayed closure underwent the same repair at 6 to 12 weeks of age. Before delayed surgery, the exposed bladder plate was cleaned with sterile saline and covered with a clear non-adherent pad, while hydration and weight gain were monitored. The operation included closure of the bladder and posterior urethra and reconstruction of the lower abdominal wall, pelvic floor, and female external genitalia. Pelvic osteotomy was reserved for predefined anatomical findings or excessive closure tension. Perioperative care was standardized in both groups.
Participants were assessed on postoperative days 7, 14, and 30. Successful bladder closure on postoperative day 30 required an intact deep bladder and abdominal-wall closure without full-thickness wound dehiscence, urinary fistula, or urinary leakage requiring repeat closure or urinary diversion. Secondary outcomes were wound dehiscence, surgical-site infection, urinary fistula, blood transfusion, reoperation, readmission, hospital stay, and adverse events. The primary analysis followed the intention-to-treat principle.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Primary single-stage closure performed within 72 hours of birth. The procedure included closure of the bladder and posterior urethra and reconstruction of the lower abdominal wall, pelvic floor, and female external genitalia during one anaesthetic. Pelvic osteotomy was reserved for predefined anatomical findings or excessive closure tension.
Primary single-stage closure performed at 6 to 12 weeks of age using the same operative checklist and repair. Before surgery, the exposed bladder plate was cleaned with sterile saline and covered with a clear non-adherent pad, with monitoring of hydration and weight gain. Pelvic osteotomy was reserved for predefined anatomical findings or excessive closure tension.
Time frame: Postoperative day 30
Number and percentage of participants with an intact deep bladder and abdominal-wall closure without full-thickness abdominal wound dehiscence, urinary fistula, or urinary leakage requiring repeat closure or urinary diversion on or before postoperative day 30.
Time frame: From surgery through postoperative day 30
Number and percentage of participants with partial or complete, superficial or deep disruption of the operative wound within 30 days after surgery.
Time frame: From surgery through postoperative day 30
Number and percentage of participants with inflammatory signs at the operative site, with or without purulent discharge or positive culture, requiring antibiotic or surgical treatment within 30 days after surgery.
Time frame: From surgery through postoperative day 30
Number and percentage of participants with continuous urinary leakage from the wound or another site after surgery, confirmed clinically or by imaging and requiring continued drainage or intervention.
Time frame: From the start of surgery through hospital discharge, up to 30 days after surgery
Number and percentage of participants who received a blood transfusion during the operative or perioperative period.
Time frame: From surgery through postoperative day 30
Number and percentage of participants who underwent a repeat surgical procedure related to the primary closure within 30 days after surgery.
Time frame: From discharge through postoperative day 30
Number and percentage of participants readmitted to hospital within 30 days after surgery.
Time frame: From surgery to hospital discharge, up to 30 days after surgery
Duration of the index postoperative hospital stay, measured in days from surgery to discharge.
Time frame: From surgery through postoperative day 30
Number and percentage of participants with at least one recorded adverse event within 30 days after surgery.
Khyber Teaching Hospital
Other
Primary Single-Stage Early Versus Delayed Closure of Bladder Exstrophy in Female Patients: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05690594
Bladder Exstrophy, Congenital Abnormalities
Bron, France
View Trial DetailsNCT01878500
Bladder Exstrophy, Bladder Exstrophy and Epispadias Complex
Baltimore, Maryland, United States
View Trial DetailsNCT00863070
Bladder Exstrophy, Congenital Abnormalities
Farmington, Connecticut, United States
View Trial DetailsNCT04626167
Bladder Absence, Bladder Dysfunction
Rochester, Minnesota, United States
View Trial Details